TOVX

THERIVA BIOLOGICS INC

• TipRanks·21h ago

  Theriva Biologics Advances VCN-01 Into Pivotal Phase 3

• TipRanks·22h ago

  Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA

• Benzinga·22h ago

  Theriva Biologics Announces It Receives FDA's General Agreement For Phase 3 Clinical Study Of VCN-01 To Treat Metastatic Pancreatic Adenocarcinoma

• TipRanks·03/13 13:38

  Theriva Biologics price target lowered to $4 from $7 at Alliance Global

• Seeking Alpha·03/12 19:12

  Theriva Biologics GAAP EPS of -$2.08

• Benzinga·03/12 12:35

  Theriva Biologics Q4 EPS $(0.12) Beats $(0.50) Estimate

• TipRanks·03/12 12:07

  Theriva Biologics reports FY25 EPS ($2.08) vs. ($19.03) last year

• TipRanks·03/12 12:05

  Theriva Biologics sees cash runway into 1Q27

• Dow Jones·03/12 12:01

  Press Release: Theriva(TM) Biologics Reports Full-Year 2025 Operational Highlights and Financial Results

• Dow Jones·03/12 12:01

  Press Release: Theriva(TM) Biologics Reports -2-

• Benzinga·03/03 21:05

  12 Health Care Stocks Moving In Tuesday's After-Market Session

• TipRanks·02/27 17:25

  Alliance Global Partners Sticks to Its Buy Rating for Theriva Biologics (TOVX)

• Benzinga·02/23 21:05

  12 Health Care Stocks Moving In Monday's After-Market Session

• Benzinga·02/19 21:06

  12 Health Care Stocks Moving In Thursday's After-Market Session

• Benzinga·02/19 09:25

  Why Etsy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket